Nachrichten zur Lantheus Holdings Inc. Aktie

Lantheus Aktie: Guter Einstiegszeitpunkt

Kulmbach (www.aktiencheck.de) - Lantheus-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Lantheus wird mit seinen Chancen bei Alzheimer-Diagnostik unterschätzt

Lantheus Holdings (LNTH) ist bisher stark abhängig vom PSMA PET-Bildgebungsmittel Pylarify für die Erkennung von Prostatakrebszellen. Trotz übertroffener Erwartungen im…

Lantheus Holdings: A Growing Business With Dominant Market Share

…

15:06: Lantheus Holdings - LNTH: Was war das? Mega-Absturz nach den Quartalszahlen!

Jetzt Bärenflagge bei der Lantheus-Aktie (LNTH)! Leerverkauf starten?Durchwachsene Zahlen oder Trump-/Kennedy-Effekt?Lantheus Hodings (LNTH) – ISIN US5165441032Rückblick: Heftige Volatilität mit ein.…

Lantheus Holdings - LNTH: Was war das? Mega-Absturz nach den Quartalszahlen!

Jetzt Bärenflagge bei der Lantheus-Aktie (LNTH)! Leerverkauf starten? Durchwachsene Zahlen oder Trump-/Kennedy-Effekt? Lantheus Hodings (LNTH) - ISIN US5165441032 Rückblick: Heftige…

Lantheus Announces Share Repurchase Program

BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the…

Lantheus Holdings: Q3 Results Were Good But Market Overreacted

…

Lantheus Holdings: Führend im Radiopharmaka-Markt mit starkem Wachstumspotenzial

?PYLARIFY als Haupttreiber : Mit 69,3 % des Quartalsumsatzes zeigt PYLARIFY seine Marktführerschaft in der Prostatakrebsdiagnostik und trägt maßgeblich…

Billion-dollar Deals in Radiopharmaceuticals Catch Investor Attention

Recent mergers and acquisitions and partnership deals in the medical industry are showing signs of increasing investor interest in the…

Radiopharm Theranostics ‘Extends Runway’ to Key Milestones with AU$70M Investments: Report

DescriptionThe AU$7.5 million strategic investment from Lanthues Holdings signals a strong endorsement of Radiopharm Theranostics’ (ASX:RAD) technology, extending the companys…

Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access

BEDFORD, Mass., July 10, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company…

Radiopharm Theranostics Completes A$70 Million Placement

Radiopharm Theranostics Limited (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, has…

Radiopharm Receives Strategic Investment for up to A$18 million

SYDNEY, June 20, 2024 (GLOBE NEWSWIRE) -- Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or the Company), a developer of…

Radiopharm Receives Strategic Investment for up to A$18 million

Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or the Company), a developer of diagnostic and therapeutic radiopharmaceutical products, has entered into strategic…

Lantheus Holdings: Powerful First Quarter

…

Lantheus Holdings, Inc. (LNTH) Q1 2024 Earnings Call Transcript

…

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

BEDFORD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company…

Lantheus Holdings, Inc. (LNTH) Q4 2023 Earnings Call Transcript

…

Lantheus Holdings (LNTH) Exceeds Market Returns: Some Facts to Consider

Lantheus Holdings (LNTH) concluded the recent trading session at $64.49, signifying a +0.25% move from its prior days close.…

Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference

BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company…

Lantheus Holdings: Huge Catalysts Ahead And Cheap Valuation

…

Lantheus to Present at the Jefferies London Healthcare Conference

BEDFORD, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company…

Lantheus Holdings, Inc. (LNTH) Q3 2023 Earnings Call Transcript

…

Lantheus Holdings, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

Lantheus Reports Third Quarter 2023 Financial Results

BEDFORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused…

Lantheus to discontinue radiotherapy Azedra

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lantheus Subsidiary to Stop Production, Promotion of Azedra

Lantheus Subsidiary to Stop Production, Promotion of Azedra...…

Form 8-K Lantheus Holdings, Inc. For: Aug 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: CEO verkauft Aktien von Lantheus Holdings im Wert von 750.982$

Heino, Mary Anne - Vorstand - Tag der Transaktion: 2023-08-11...…

Form 10-Q Lantheus Holdings, Inc. For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Lantheus Holdings, Inc. For: Aug 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Investors Heavily Search Lantheus Holdings, Inc. (LNTH): Here is What You Need to Know

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be…

Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00 a.m. Eastern Time

BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that…

Lantheus Holdings (LNTH) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Lantheus Holdings (LNTH) closed at $89.21, marking a -1.7% move from the previous day....…

Here is What to Know Beyond Why Lantheus Holdings, Inc. (LNTH) is a Trending Stock

Zacks.com users have recently been watching Lantheus Holdings (LNTH) quite a bit. Thus, it is worth knowing the facts that…

Lantheus Holdings (LNTH) Gains As Market Dips: What You Should Know

In the latest trading session, Lantheus Holdings (LNTH) closed at $82.40, marking a +1.22% move from the previous day....…

Lantheus Holdings (LNTH) Dips More Than Broader Markets: What You Should Know

Lantheus Holdings (LNTH) closed the most recent trading day at $81.41, moving -1.26% from the previous trading session....…

Lantheus and GlobalFoundries have been highlighted as Zacks Bull and Bear of the Day

Lantheus and GlobalFoundries are part of the Zacks Bull and Bear of the Day article....…

Bull of the Day: Lantheus (LNTH)

Medical diagnostics leader in prostate cancer is driving 34% sales and 32% EPS growth...…

Lantheus Holdings (LNTH) Gains But Lags Market: What You Should Know

In the latest trading session, Lantheus Holdings (LNTH) closed at $83.92, marking a +1.17% move from the previous day....…

Lantheus Holdings (LNTH) Stock Sinks As Market Gains: What You Should Know

Lantheus Holdings (LNTH) closed at $82.95 in the latest trading session, marking a -1.88% move from the prior day....…

Investors Heavily Search Lantheus Holdings, Inc. (LNTH): Here is What You Need to Know

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be…

Lantheus Holdings (LNTH) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Lantheus Holdings (LNTH) closed at $92.20, marking a -0.72% move from the previous day....…

Bet on These 4 Top-Ranked Liquid Stocks for Robust Returns

Here are four top-ranked liquid stocks, Chipotle Mexican Grill (CMG), Meta Platforms (META), Lantheus Holdings (LNTH) and eGain (EGAN), which…

Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

BEDFORD, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to…

dpa-AFX ProFeed